Healthcare Services

A Significant Growth Driver for the Geographic Atrophy Market Is the Rising Prevalence Of Age-Related Macular Degeneration Driving Geographic Atrophy Market Growth Due To Aging Population Trends

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Geographic Atrophy Market Between 2026 And 2030?

The geographic atrophy market size has experienced rapid expansion in recent years. It is projected to increase from $2.11 billion in 2025 to $2.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. This growth during the historic period can be linked to factors such as aging population growth, the prevalence of age-related macular degeneration, advances in retinal imaging, early ophthalmic drug development, and clinical research funding.

The geographic atrophy market size is projected to experience substantial growth in the upcoming years. It is predicted to reach $3.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period is primarily driven by the approval of novel therapies, the broadening of screening programs, the integration of AI-based imaging, heightened patient awareness, and the growth of specialty eye care services. Significant trends identified for this period include the rising development of complement inhibitor therapies, an increasing focus on the early diagnosis of retinal disorders, greater investment in novel ophthalmic drugs, the expansion of imaging technologies for disease monitoring, and an increase in clinical trials for AMD treatments.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21984&type=smp

What Key Drivers Are Influencing The Growth Of The Geographic Atrophy Market?

The geographic atrophy market is anticipated to expand due to the rising occurrence of age-related macular degeneration. Age-related macular degeneration (AMD) refers to an eye ailment that impairs the central retina in older individuals, hindering their ability to discern fine details. The primary factor contributing to the widespread nature of age-related macular degeneration is the aging population, as extended lifespans and the natural process of aging progressively harm the eyes, increasing their susceptibility to the condition over time. Treatments for geographic atrophy assist patients with age-related macular degeneration (AMD) by decelerating the advancement of retinal damage and safeguarding existing vision. Illustratively, a January 2024 report from Medical News Today, a US-based digital media company, projects that global cases of age-related macular degeneration will increase from 196 million to 288 million by 2040. Consequently, the growing prevalence of age-related macular degeneration is fueling the expansion of the geographic atrophy market.

Which Market Segments Are Examined In The Geographic Atrophy Market Study?

The geographic atrophy market covered in this report is segmented –

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drug Types

2) By Diagnosis: Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal, Oral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab, Aflibercept, Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan, Lfg316

3) By Neuroprotective Agents: Latanoprost, Brimonidine

4) By Other Drug Types: Steroids, Retinoids, Combination Therapy

What Key Trends Are Influencing The Development Of The Geographic Atrophy Market?

Leading companies in the geographic atrophy market are dedicating efforts to pioneering therapies, such as complement inhibitor therapy, to create more advanced treatments for geographic atrophy. Complement inhibitor therapy functions by mitigating an overactive immune response linked to certain diseases, helping to protect healthy cells from damage and slow down disease progression. For instance, in February 2025, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced the Food and Drug Administration, a US-based government agency, had approved IZERVAY (avacincaptad pegol intravitreal solution) for geographic atrophy. This approval allows IZERVAY to be administered without limits on the duration of dosing for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This decision offers increased adaptability for managing GA, providing patients and healthcare providers with longer-term treatment options.

Who Are The Primary Competitors In The Geographic Atrophy Market?

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc, Ocugen Inc, Kodiak Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio, Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Therapeutics

Read the full geographic atrophy market report here:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Geographic Atrophy Market?

North America was the largest region in the geographic atrophy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Geographic Atrophy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21984&type=smp

Browse Through More Reports Similar to the Global Geographic Atrophy Market 2026, By The Business Research Company

Excavator Global Market Report

https://www.thebusinessresearchcompany.com/report/excavator-global-market-report

Vanadium Global Market Report

https://www.thebusinessresearchcompany.com/report/vanadium-global-market-report

Genotyping Global Market Report

https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795